Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adicon HoldingsADCNF 75 PS Ratio is 1.25 as of Jul. 25, 2026, which is 21% below its 10-year median of 1.59. GuruFocus rates ADCNF with a GF Score™ of 75/100 and a GF Value™ of $1.19. The stock has 6 warning signs investors should review. Among 200 Medical Diagnostics & Research companies, Adicon Holdings ranks better than 83% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Adicon Holdings's share price is $0.65.
Adicon Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.52. Hence, Adicon Holdings's PS Ratio for today is 1.25.
The historical rank and industry rank for Adicon Holdings's PS Ratio or its related term are showing as below:
ADCNF'
s PS Ratio Range Over the Past 10 Years
Min: 0.84 Med: 1.59 Max: 2.5
Current: 0.97
During the past 6 years, Adicon Holdings's highest PS Ratio was 2.50. The lowest was 0.84. And the median was 1.59.
ADCNF's PS Ratio is ranked better than 83% of 200
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.715
vs ADCNF: 0.97
Adicon Holdings Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Adicon Holdings was -5.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -18.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -4.80% per year.
During the past 6 years, Adicon Holdings's highest 3-Year average Revenue per Share Growth Rate was 3.90% per year. The lowest was -18.40% per year. And the median was -9.00% per year.
Back to Basics: PS Ratio
Adicon Holdings (OTCPK:ADCNF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Adicon Holdings PS Ratio Related Terms
Adicon Holdings PS Ratio Historical Data
* Premium members only.
The historical data trend for Adicon Holdings's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Adicon Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adicon Holdings PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Adicon Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Adicon Holdings's Share Price of today is $0.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adicon Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.52.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Adicon Holdings (ADCNF) has a PS Ratio of 1.25 as of Jul. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Adicon Holdings and its competitors. This is 21% below median its historical median of 1.59. Over the past decade, Adicon Holdings' PS Ratio has ranged from 0.84 to 2.50. According to the industry distribution chart, Adicon Holdings ranks #34 out of 200 companies in the Medical Diagnostics & Research industry, placing it in the top 17%.
Is Adicon Holdings' PS Ratio too high?
Adicon Holdings' current PS Ratio of 1.25 is 21% below median its 10-year median of 1.59. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 2.50. The Medical Diagnostics & Research industry median PS Ratio is 2.72. Adicon Holdings' value of 1.25 is 54% below this industry median. Based on the distribution chart, Adicon Holdings ranks #34 out of 200 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Adicon Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Adicon Holdings' PS Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Adicon Holdings ranks #34 out of 200 companies for PS Ratio. This places Adicon Holdings in the top 17% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.72. Adicon Holdings' value of 1.25 is 54% below this benchmark. Historically, Adicon Holdings' own PS Ratio has ranged from 0.84 to 2.50 over the past decade. While the company's 10-year median is 1.59 vs. the industry median of 2.72, Adicon Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.72, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adicon Holdings's current PS Ratio of 1.25 is 54% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Adicon Holdings and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adicon Holdings's current PS Ratio is 1.25, which is 21% below median its own 10-year median of 1.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicon Holdings stock overvalued right now?
Adicon Holdings (ADCNF) has a current PS Ratio of 1.25. The stock's GF Value™ is $1.19, compared to a current price of $0.65 — trading 45.4% below its estimated fair value. The current PS Ratio is 1.25, which is 21% below median its 10-year median of 1.59 and 54% below the Medical Diagnostics & Research industry median of 2.72. Adicon Holdings' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Adicon Holdings (ADCNF), the current PS Ratio is 1.25 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adicon Holdings (ADCNF) Overvalued in 2026?
Based on GuruFocus' analysis, Adicon Holdings stock appears to be undervalued.
The current stock price of $0.65 is trading 45.4% below its estimated GF Value™ of $1.19.
Key valuation signals for ADCNF:
PS Ratio: 1.25 (21% below median its 10-year median of 1.59)
GF Value™: $1.19 vs. price of $0.65 (45.4% below fair value)
Industry Position: 54% below the Medical Diagnostics & Research median (#34 of 200)
No single metric tells the full story. See the ADCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adicon Holdings Ltd is a ICL service provider in China. It offers comprehensive testing services to hospitals and health check centers through an integrated network of self-operated laboratories across China. Its testing services platform includes clinical laboratories, pathology laboratories, reproductive genetics laboratories, gene laboratories, and mass spectrometry laboratories, consisting of over 4,000 medical diagnostic tests, the introduction of over 300 new high-end diagnostic tests.
75GF Score
Get the complete analysis for ADCNF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADCNF has been successfully added to your 
